Faron Pharmaceuticals Oy (DI) (FARN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 177.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 262.50
  • 52 Week Low: 141.67
  • Currency: UK Pounds
  • Shares Issued: 112.92m
  • Volume: 12,105
  • Market Cap: £200.44m

Latest ShareCast News

Faron narrows first-half losses as it advances its lead asset

By Josh White

Date: Wednesday 27 Aug 2025

(Sharecast News) - Faron Pharmaceuticals reported a series of first-half clinical and financial milestones on Wednesday, as it advanced its lead asset, bexmarilimab, through late-stage development in high-risk myelodysplastic syndromes (HR-MDS).

Faron secures FDA pathway for lead cancer therapy

By Josh White

Date: Monday 18 Aug 2025

(Sharecast News) - Faron Pharmaceuticals said on Monday that it has secured a clear regulatory pathway for the potential approval of its lead cancer therapy bexmarilimab, following positive feedback from the US Food and Drug Administration.

Faron Pharmaceuticals appoints chief business officer

By Josh White

Date: Wednesday 21 May 2025

(Sharecast News) - Faron Pharmaceuticals announced the appointment of Ralph Hughes as its chief business officer on Wednesday, effective 28 May, as the clinical-stage biopharma firm sharpened its focus on commercial strategy, business development and market access.

Faron enters financing arrangement with Heights ... 03-Apr-2025 ShareCast
Faron identifies final patient in BEXMAB phase t... 31-Jan-2025 ShareCast
Faron Pharmaceuticals reports regulatory progres... 02-Dec-2024 ShareCast
Faron announces promising MDS trial results 27-Nov-2024 ShareCast
Faron Pharmaceuticals files new patent for Cleve... 11-Nov-2024 ShareCast
Faron Pharmaceuticals candidate gets FDA fast tr... 27-Aug-2024 ShareCast
Faron gets positive FDA feedback on bexmarilimab... 11-Jul-2024 ShareCast
Faron Pharmaceuticals extends funding agreement ... 30-Apr-2024 ShareCast
Faron Pharmaceuticals CFO stands down 15-Apr-2024 ShareCast
Faron Pharmaceuticals taps Juho Jalkanen for CEO 08-Apr-2024 ShareCast
Faron shares jump on encouraging trial data 18-Mar-2024 ShareCast
Faron Pharmaceuticals reports year of clinical p... 13-Mar-2024 ShareCast
Faron Pharmaceuticals shores up cash with EUR 3.... 04-Mar-2024 ShareCast
Faron launches second phase of leukaemia treatme... 09-Jan-2024 ShareCast
Faron unveils promising antibody study results 11-Dec-2023 ShareCast
Faron publishes cancer immunotherapy study findi... 07-Dec-2023 ShareCast
Faron reveals details of next stage of bexmarili... 06-Nov-2023 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

FARN Market Data

Currency UK Pounds
Share Price 177.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 262.50
52 Week Low 141.67
Volume 12,105
Shares Issued 112.92m
Market Cap £200.44m

FARN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average41.46% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average54.55% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 1
Strong Sell 1
Total 5
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

FARN Dividends

No dividends found

Trades for 14-Oct-2025

Time Volume / Share Price
13:43 225 @ 177.00p
12:01 2,300 @ 172.50p
10:09 1,692 @ 177.00p
10:08 6,000 @ 172.25p

FARN Key Personnel

CEO Juho Jalkanen
Chair Tuomo Pätsi

Top of Page